Table 4 Clinical presentations and treatments for chronic dialysis patients versus patients with normal renal function
Dialysis | Control | |||||||
|---|---|---|---|---|---|---|---|---|
Endogenous (N = 25) | Exogenous (N = 7) | Endogenous (N = 31) | Exogenous (N = 26) | |||||
Clinical & laboratory | ||||||||
Days from symptom onset to ophthalmologists’ visit | 1–30 (Median: 2 days) | 1–7 (Median: 2 days) | 1–30 (Median: 3 days) | 1–30 (Median: 3 days) | ||||
Recent trauma or surgery | 0 | 0% | 7 | 100.0% | 0 | 0% | 26 | 100.0% |
Days post eye surgery | 3–20 (Median: 4 days) | 1–35 (Median: 4 days) | ||||||
Blurred vision | 14 | 56% | 2 | 28.5% | 26 | 83.9% | 25 | 96.2% |
Ophthalmalgia | 25 | 100%# | 7 | 100%* | 22 | 71.0% | 20 | 76.9% |
Peri-ocular swelling | 25 | 100%# | 6 | 85.7%* | 10 | 32.2% | 2 | 7.6% |
Fever | 8 | 32.0% | 0 | 0% | 17 | 54.8% | 0 | 0% |
Septic shock | 2 | 8.0% | 0 | 0% | 5 | 16.1% | 0 | 0% |
Respiratory failure | 2 | 8.0% | 0 | 0% | 1 | 3.2% | 0 | 0% |
Dialysis access infection | 4 | 14.8% | 0 | 0% | 0 | 0% | 0 | 0% |
Leukocytosis | 11 | ± 5 | 10 | ± 6 | 10 | ± 4 | 11 | ± 5 |
Serum CRP level | 71 | ± 75 | 16 | ± 10 | 133 | ± 105 | 43 | ± 56 |
Microbiology | ||||||||
Bacteremia | 8 | 32.0% | 0 | 0% | 13 | 41.9% | 0 | 0% |
Fungemia | 0 | 0 | 0 | 0% | 0 | 0% | 0 | 0% |
Positive vitreous culture | 13 | 52.0% | 4 | 57.1% | 18 | 58.1% | 19 | 73.1% |
Treatment | ||||||||
IVI | 12 | 48.0%+ | 7 | 100% | 29 | 93.5% | 25 | 96.2% |
TPPV | 2 | 8.0% | 3 | 42.9% | 2 | 6.5% | 10 | 38.5% |
Enucleation | 5 | 20.0% | 0 | 0% | 6 | 19.4% | 1 | 3.8% |
Parenteral antibiotic only | 8 | 32.0% | 0 | 0% | 0 | 0% | 0 | 0% |